SUMMARY
coronary artery disease, are also efficacious in inhibiting platelet aggregation.1)-5) Typical slow channel blocking drugs, such as nifedipine and verapamil, inhibit the secondary (TXA2-dependent) wave of ADP-induced platelet aggregation and appear to have beneficial effects on prostagladin metabolism in the event of myocardial ischemia.6) Nisoldipine, a new calcium channel blocker, is a dihydropyridine derivative that is structurally similar to nifedipine (Fig. 1) . It has stronger systemic and coronary hemodynamic effects7)-9) than other dihydropyridines, but it may also have a potent effect on prostaglandin metabolites.
Although an intravenous infusion of nisoldipine has been shown to increase the myocardial supply in excess of demand,10)-12) only a few studies have examined its effects on prostaglandin metabolism after either intravenous or oral administration. This study investigated the effects of a low, oral dose of nisoldipine on systemic and coronary hemodynamics, and on prostaglandin metabolism in patients with chronic, stable angina pectoris. The rationale for this study was that low, oral doses of the medication would be both economically and physiologically beneficial. Further, a deeper knowledge of the effects of nisoldipine on the prostaglandin metabolites is desired, for they are known to play an important role in the pathogenesis of ischemic heart disease (IHD Jpn. Heart J. M ay 1990
METHODS

Selection of patients:
Patients with a predominant history of angina while at rest or an ST segment elevation during episodes of chest pain were excluded from this study. Similarly, patients with severe hypertension, a valvular heart disease, signs of congestive heart failure, intraventricular conduction disturbances, or any other condition likely to influence the ST segment "at rest" were also excluded.
Ten patients, ranging in age from 44 to 65 (mean age:50), with stable angina pectoris were tested. All had reproducible, exercise-induced angina, associated with horizontal or downsloping ST segment depression of 0.1mV or more for at least 80msec after the J point of the baseline of a treadmill test. Each had had at least one fixed coronary artery stenosis (a 70% or greater narrowing of the luminal diameter), determined by routine coronary arteriography. The left ventricular contraction was normal in 8 patients, while the remaining 2 showed hypokinesis.
Beta blockers, calcium blocking drugs, or any other agents that might affect the exercise data were discontinued 14 days prior to the start of the exercise regimen. Platelet-inhibitory drugs, such as aspirin, sulfapyrazone or other agents affecting the prostaglandin release, were also discontinued 7 days prior to testing. Finally, patients did not receive any nitrates except sublingual nitroglycerin within 6 hours of testing.
The test procedure: All selected patients underwent a graded, supine bicycle exercise test devised by Minjhart. The exercise was started at 50 watts, with the work load being increased 25 watts every 3 min up to each patient's optimal work load. The exercise was terminated on complaint of a chest pain or on observation of a 0.1mV ST segment depression, with horizontal or downsloping patterns, for 80msec from the J point. Individual exercise thresholds had been determined at least 90min prior to the start of exercise and patients underwent their predetermined work loads.
Measurements were taken in the following manner. Under local anesthesia, a sheath was inserted into an antecubital vein, through which a 7Fr thermodilution catheter (Wilton Lab.) was inserted and positioned in the mid-coronary sinus (CS). The positioning of the catheter was then carefully checked by fluoroscopy. The coronary sinus blood flow (CSF) was measured and calculated by the method described by Ganz et al.16 
